SecBot SecBot
Insider Cluster (7 insiders) ·Filed Jun 3, 2026

NVCR

NovoCure Ltd
NEUTRAL
Impact 2/10
Horizonimmediate Processed5mo ago
Insider cluster: 2 insiders, $93K total
Actionable Insight • Neutral

This is a routine director-level liquidity event with no informational content. The identical block sizes and single-day execution point to a pre-arranged plan, not a bearish signal. Monitor for any C-suite selling or material changes in the business, but this filing alone warrants no action.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$17.99
T+0 close · Jun 3, 2026 · via day close
Latest settled
−0.94%
T+60 · $17.82
Vs SPY
−2.83%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 4 $17.99entry
  2. T+1 · 6mo ago −4.61%α −2.02% · $17.16
  3. T+5 · 5mo ago −1.56%α +1.00% · $17.71
  4. T+20 · 4mo ago −4.39%α −3.02% · $17.20
  5. T+60 · 3mo ago −0.94%α −2.83% · $17.82

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Seven NovoCure directors sold identical blocks of 2,945 shares each at $15.77 on June 2, 2026, for a total of $325K. The uniform size and timing suggest a pre-arranged plan or coordinated liquidity event rather than opportunistic selling. At 0.018% of market cap, the dollar value is trivial and not material.

Key Financial Metrics

Direction
selling
Total Value
$325.1K
Insiders
7

Key Facts

  • Seven directors each sold exactly 2,945 shares at $15.7707 on June 2, 2026
  • Total open-market sales: $325,113
  • Sales represent 0.018% of NVCR's $1.8B market cap
  • No C-suite executives (CEO/CFO) participated in the sales
  • Identical share amounts and same execution date strongly suggest a pre-arranged plan or tax-related transaction

Financial Impact

$325K in total insider sales, 0.018% of market cap

Risk Factors

  • No material risk identified from this filing

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
77% bullish (13 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-NVCR-1780520052321

Track record

20 reports on NVCR

Performance horizon

5 of 7 bullish or bearish reports moved the stock their way by T+1. Best: +19.75% at T+20 after the Feb 27, 2026 report. 5 of 7 went positive at some point.

Filters
  1. Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $11.83 to $11.30 Now $11.30 −4.48% ▼ −4.48% −2.57% vs SPY
  2. Nov 9, 20267d ago SC 13G/A Neutral 3/10 Entry $11.81 to $11.99 Now $11.30 −4.32% ▲ +1.52% +0.21% vs SPY
  3. Nov 9, 20267d ago 144 Neutral 2/10 Entry $11.81 to $11.99 Now $11.30 −4.32% ▲ +1.52% +0.21% vs SPY
  4. Nov 9, 20267d ago 8-K Bearish 6/10 Entry $12.53 to $11.81 Now $11.30 +9.82% ▲ +5.75% +5.38% vs SPY
  5. Oct 29, 202618d ago 8-K Bullish 6/10 Entry $13.11 to $13.15 Now $11.30 −13.81% ▲ +0.31% +2.08% vs SPY
  6. Oct 1, 20266w ago 8-K Bullish 6/10 Entry $15.92 to $14.94 Now $11.30 −29.02% ▼ −6.16% −6.90% vs SPY
  7. Sep 9, 20269w ago 8-K Neutral 2/10 Entry $15.63 to $15.35 Now $11.30 −27.70% ▼ −1.79% −1.19% vs SPY
  8. Sep 1, 202610w ago 8-K Neutral 3/10 Entry $17.38 to $17.83 Now $11.30 −34.98% ▲ +2.59% +2.15% vs SPY
  9. Jul 23, 202616w ago 8-K Bullish 7/10 Entry $19.99 to $17.65 Now $11.30 −43.47% ▼ −11.71% −11.81% vs SPY
  10. Jun 30, 202619w ago 8-K Bullish 7/10 Entry $15.15 to $15.78 Now $11.30 −25.41% ▲ +4.16% +4.29% vs SPY
Showing 10 of 20

US Market Status

Market Closed · Opens Wed (10h 44m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 3, 2026